Aquatic Therapy and Autism Spectrum Disorders

Autism Spectrum Disorder Clinical Trial

— AT&ASD  

Official title:

Aquatic Therapy and Autism Spectrum Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03195244
• Other study ID #: AT&ASD
• Status: Completed
• Phase: N/A
• Start date: June 12, 2017
• Est. completion date: April 12, 2022

Study information

• Verified date: April 2022
• Source: Panhandle Eye Group, LLP
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To compare the efficacy of one-on-one versus group-based aquatic therapy on the social interactions, behaviors and physical activities of children with autism spectrum disorders (ASDs).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: April 12, 2022
• Est. primary completion date: April 12, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Years to 17 Years

Eligibility

Eligibility criteria:

• DSM-V diagnosis of Autism Spectrum Disorder or DSM-IV diagnosis of Asperger's syndrome or high functioning atypical autism or pervasive development disorder - not otherwise specified or else the typical clinical findings and suspicion of an ASD

• Treatment naïve to prior aquatic therapy

Exclusion criteria:

• Not willing to undergo an investigational treatment

• Unable to cooperate well enough to safely participate in aquatic therapy under the protocol guidelines

• Known allergies to pool chemicals

• Other significant co-morbidities which may include (but is not limited to): severe cerebral palsy with low motor function, advanced pulmonary disease, home oxygen requirement, spina bifida with low motor function, permanent feeding tubes, poorly controlled seizure disorder, chronic indwelling urinary catheters or any condition causing severe cognitive impairment

Related Conditions & MeSH terms

• Autism Spectrum Disorder
• Autistic Disorder
• Child Development Disorders, Pervasive

Intervention

Other:
• Aquatic Physical Therapy
Swim Whisperer's Aquatic Therapy Sessions

Locations

Country	Name	City	State
United States	Turn Center	Amarillo	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Sloan W. Rush, MD

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in PedsQL Score	Survey	Baseline and 10 weeks after intervention